gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NYSE · TRLVHealthcarePharmaceuticals

Trulieve Cannabis Corp. (TRLV)

$11.60+0.52%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$11.60▲ 2.56% in range
Sep 11, 2026Low $9.97 · High $12.54Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Trulieve Cannabis closed at $11.60 on Nov 4, up 0.52%, 7.5% below its highest close since Sep 11. Volume of 2.2M shares was 1.75× its 20-day average (above normal).

Split-adjusted performance: +8.9% over one month.

In the quarter ended Jun 30, 2026, revenue was $270.95M, with a net margin of -149.8%.

Short interest was 7.3M shares at the Oct 15 settlement, up 12.8% from the prior report (4.4% of float, 4.5 days to cover).

Market cap$2.23B192.6M shares
Revenue · quarter$271.0M—
Diluted EPS$-2.10—
P/E · TTM—
Net margin-149.8%Gross 59.9%
Dividend yieldNone
Range since Sep 119.97 – 12.54−7.5% from high
Volume2.2M1.75× 20-day avg
Volatility · 60d—Annualised
Short % of float4.4%4.5 days to cover
Net cash-$154.8MCash $325.4M
Next earnings—Not scheduled
Split-adjusted performance
1W +9.2%1M +8.9%3M —6M —YTD —1Y —3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin41
Value (low P/E)—
Size82

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short7.3M+12.8% vs prior
Days to cover4.5Settled Oct 15
% of float4.4%
Short vol. 10d45.5%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
TRLVTrulieve Cannabis$11.60+0.52%——−149.8%—$2.23B
SEPNSepterna$47.88+9.57%+93.8%+22375.6%−48.7%—$2.23BCompare
ZYMEZymeworks$30.94+2.69%+12.1%−90.6%−980.8%—$2.22BCompare
PRGOPERRIGO$15.83+0.83%+29.1%−3.2%7.3%—$2.20BCompare
AUPHAurinia Pharmaceuticals$17.11+3.32%+5.3%+13.9%37.9%7.3$2.29BCompare
BHVNBiohaven$15.24−2.37%+51.8%———$2.30BCompare
IMNMImmunome$19.52−3.89%−16.1%−100.0%——$2.30BCompare
VERAVera Therapeutics$31.97+4.10%−12.6%———$2.30BCompare
PVLAPalvella Therapeutics$162.28+6.11%+24.7%———$2.34BCompare

News about Trulieve Cannabis

All news →
Zacks Industry Outlook Highlights ICU Medical, Neogen and Trulieve CannabisZacks Investment Research · Oct 12, 2026Neutral

Quick answers

What does Trulieve Cannabis do?
Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products.
What is TRLV's market cap?
$2.23B, based on the Nov 4 close of $11.60.
Does Trulieve Cannabis pay a dividend?
No regular cash dividend has been paid in the last year.
How much of TRLV is sold short?
7.3M shares, 4.4% of float, as of Oct 15, 2026.
What sector is TRLV in?
Healthcare, in the Pharmaceuticals industry.

About Trulieve Cannabis

Trulieve Cannabis Corp is a vertically integrated cannabis company that grows, produces, and sells cannabis products. It has licenses to operate in Arizona, Colorado, Connecticut, Florida, Georgia, Maryland, Ohio, Pennsylvania, and West Virginia, where it sells medical cannabis products. In addition, the company sells cannabis products for adult use in Arizona, Colorado, Connecticut, Maryland, and Ohio. The firm's operations are substantially located in Florida and, to a lesser extent, in Arizona and Pennsylvania.

HQ: Tallahassee, FL5,000 employeesListed Sep 26, 2018trulieve.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology